Mutation of Prkar1a causes osteoblast neoplasia driven by dysregulation of protein kinase A.

Mol Endocrinol 2008 Feb 11;22(2):430-40. Epub 2007 Oct 11.

Department of Molecular Virology, Immunology, and Molecular Genetics, The Ohio State University, 420 West 12th Avenue, TMRF 546, Columbus, OH 43210, USA.

Carney complex (CNC) is an autosomal dominant neoplasia syndrome caused by inactivating mutations in PRKAR1A, the gene encoding the type 1A regulatory subunit of protein kinase A (PKA). This genetic defect induces skin pigmentation, endocrine tumors, myxomas, and schwannomas. Some patients with the complex also develop myxoid bone tumors termed osteochondromyxomas. To study the link between the PRKAR1A mutations and tumor formation, we generated a mouse model of this condition. Prkar1a(+/-) mice develop bone tumors with high frequency, although these lesions have not yet been characterized, either from human patients or from mice. Bone tumors from Prkar1a(+/-) mice were heterogeneous, including elements of myxomatous, cartilaginous, and bony differentiation that effaced the normal bone architecture. Immunohistochemical analysis identified an osteoblastic origin for the abnormal cells associated with islands of bone. To better understand these cells at the biochemical level, we isolated primary cultures of tumoral bone and compared them with cultures of bone from wild-type animals. The tumor cells exhibited the expected decrease in Prkar1a protein and exhibited increased PKA activity. At the phenotypic level, we observed that tumor cells behaved as incompletely differentiated osteoblasts and were able to form tumors in immunocompromised mice. Examination of gene expression revealed down-regulation of markers of bone differentiation and increased expression of locally acting growth factors, including members of the Wnt signaling pathway. Tumor cells exhibited enhanced growth in response to PKA-stimulating agents, suggesting that tumorigenesis in osteoblast precursor cells is driven by effects directly mediated by the dysregulation of PKA.

Download full-text PDF

Source
http://dx.doi.org/10.1210/me.2007-0369DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2234582PMC
February 2008
32 Reads

Publication Analysis

Top Keywords

tumor cells
12
bone tumors
12
protein kinase
8
cells exhibited
8
bone
8
prkar1a+/- mice
8
cells
6
tumors
5
locally acting
4
normal bone
4
effaced normal
4
bony differentiation
4
myxomatous cartilaginous
4
acting growth
4
cartilaginous bony
4
bone architecture
4
differentiation effaced
4
architecture immunohistochemical
4
identified osteoblastic
4
bone differentiation
4

Similar Publications